In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

In a speech earlier this week which named AstraZeneca, the chancellor said life sciences would be key to boosting the economy. She announced plans to deliver an Oxford-Cambridge growth corridor ...

AstraZeneca is a company with a turbulent history ... The AZD1222 vaccine was invented by the University of Oxford and its spin-out company Vaccitech, then later licensed by AZ.

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...

After hours: January 31 at 7:55:44 PM EST Loading Chart for AZN ...

The previous government said the investment would have given the UK’s life sciences sector a boost as well as improving public health protection and pandemic preparedness. AstraZeneca became ...

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...

BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31 ... as well as backing several investment projects to make the Oxford-Cambridge axis a “European Silicon Valley”. Having already stalled ...

AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”. The drugmaker, which is Britain’s most valuable ...

AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP). The drugmaker said ...